Back to top
more

Mesa Laboratories (MLAB)

(Delayed Data from NSDQ)

$106.90 USD

106.90
31,589

-4.13 (-3.72%)

Updated Aug 2, 2024 04:00 PM ET

After-Market: $106.11 -0.79 (-0.74%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Mesa Labs, Equinox Gold, General Motors, Tesla and Ford Motor highlighted as Zacks Bull and Bear of the Day

Mesa Labs, Equinox Gold, General Motors, Tesla and Ford Motor highlighted as Zacks Bull and Bear of the Day

Kevin Cook headshot

Bull of the Day: Mesa Laboratories (MLAB)

Key M&A boosts sales & EPS, opens path to new business with Clinical Genomics Division

Mesa Labs (MLAB) Moves 4.5% Higher: Will This Strength Last?

Mesa Labs (MLAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Mesa Labs (MLAB) Lags Q1 Earnings Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -5.88% and 2.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Mesa Labs (MLAB) to Report a Decline in Earnings: What to Look Out for

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for June 14th

CPB, MLAB, TMQ, CGAU, and BHVN have been added to the Zacks Rank #5 (Strong Sell) List on June 14, 2021

Mesa Labs (MLAB) to Report Q4 Results: Wall Street Expects Earnings Growth

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mesa Labs (MLAB) Lags Q3 Earnings Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -0.68% and 5.79%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PerkinElmer (PKI) to Buy Oxford Immunotec for $591 million

PerkinElmer's (PKI) acquisition of Oxford Immunotec will expand its portfolio of advanced infectious disease testing solutions.

Mesa Labs (MLAB) Q2 Earnings and Revenues Beat Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 78.50% and 5.25%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Mesa Labs (MLAB) Q2 Earnings Expected to Decline

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bloomin' Brands, Mesa Laboratories, Intuit, Target and Microsoft highlighted as Zacks Bull and Bear of the Day

Bloomin' Brands, Mesa Laboratories, Intuit, Target and Microsoft highlighted as Zacks Bull and Bear of the Day

Keysight, Mesa, Costco and Novavax as Zacks Bull and Bear of the Day

Keysight, Mesa, Costco and Novavax as Zacks Bull and Bear of the Day

Kevin Cook headshot

Bear of the Day: Mesa Labs (MLAB)

Growth rates have stalled for this small-cap provider of quality control instruments for the medical sector

New Strong Sell Stocks for September 10th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

Mesa Labs (MLAB) Misses Q1 Earnings and Revenue Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -6.18% and -5.55%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Mesa Labs (MLAB) Q1 Earnings Expected to Decline

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mesa Labs (MLAB) Misses Q4 Earnings and Revenue Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -36.45% and -0.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mesa Labs (MLAB) Q2 Earnings Top Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 0.58% and -1.79%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mesa Labs (MLAB) Beats Q1 Earnings and Revenue Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 7.18% and 2.29%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Mesa Labs (MLAB) Q1 Earnings Expected to Decline

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.